SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 102 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $346,000 | +81.2% | 35,400 | +100.0% | 0.00% | -20.0% |
Q4 2016 | $191,000 | +5.5% | 17,700 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $181,000 | -21.6% | 17,700 | 0.0% | 0.01% | -16.7% |
Q2 2016 | $231,000 | -40.8% | 17,700 | -50.0% | 0.01% | +20.0% |
Q1 2016 | $390,000 | +139.3% | 35,400 | +100.0% | 0.01% | +25.0% |
Q4 2015 | $163,000 | +32.5% | 17,700 | 0.0% | 0.00% | +33.3% |
Q3 2015 | $123,000 | -29.3% | 17,700 | 0.0% | 0.00% | -40.0% |
Q2 2015 | $174,000 | +10.8% | 17,700 | 0.0% | 0.01% | +25.0% |
Q1 2015 | $157,000 | +1.3% | 17,700 | 0.0% | 0.00% | +33.3% |
Q4 2014 | $155,000 | +27.0% | 17,700 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $122,000 | +31.2% | 17,700 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $93,000 | +14.8% | 17,700 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $81,000 | -9.0% | 17,700 | 0.0% | 0.00% | -25.0% |
Q4 2013 | $89,000 | -1.1% | 17,700 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $90,000 | +2.3% | 17,700 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $88,000 | – | 17,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |